Gov. Zulum facilitates enrolment of 1,163 IDP children in school, Twitter drops by 8.5% in early trading over Trump's ban and more
Here are a few reasons to pick up a copy of The Guardian on Tuesday. Find these stories and much more when you grab a copy of The Guardian on Tuesday.
BioNTech CEO: 'The science we did was important'
We're not superheroes, we are scientists, BioNTech CEO Ugur Sahin has told DW. In an exclusive interview, the scientist explains how the firm will respond to a new virus strain and why he has not been vaccinated yet.
EU regulators approve BioNTech-Pfizer COVID vaccine
The decision by European Medicines Agency may allow countries to begin vaccinating before the end of the year. The vaccine's approval was widely expected, as EU nations grapple with a worsening coronavirus second wave.
UK issues allergy warning over Pfizer-BioNTech vaccine, I have no case to answer, Maina tells Court and more
Here are a few reasons to pick up a copy of The Guardian on Thursday. Find these stories and much more when you grab a copy of The Guardian on Thursday.
US pharma firm Moderna says its COVID-19 vaccine is 94.5% effective
Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.
Coronavirus: German company BioNTech says its vaccine is 90% effective
A vaccine jointly developed by German company BioNTech and US firm Pfizer has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials.